Search results :

Canagliflozin

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2
Genital infection fungal 3.7% - 11.4% 0.6% - 3.2% x
Polyuria common x
Pollakiuria common x
Urinary tract infection common, 4.3% - 5.9% 4% x x
Thirst common, 2.3% - 2.8% 0.2% x x
Constipation common, 1.8% - 2.3% 0.9% x x
Nausea common, 2.2% - 2.3% 1.5% x x
Vulvovaginal pruritus 1.6% - 3% 0% x
Rash uncommon x x
Hypotension uncommon x x
Orthostatic hypotension uncommon x x
Syncope uncommon x x
Urticaria uncommon x
Dizziness postural uncommon x x
Abdominal pain x
Angioedema x
Asthenia x
Breast disorder x
Infection x
Cystitis x
Dehydration x x
Diabetes mellitus x
Diuresis x
Fatigue x
Fracture x
Gastrointestinal disorder x
Hyperkalaemia x
Hypersensitivity x
Hypoglycaemia x x
Kidney infection x
Renal failure acute x
Nervous system disorder x
Nocturia x
Pancreatitis x
Tight foreskin x x
Polymorphic light eruption x
Prurigo x
Pruritus x
Convulsion x
Sunburn x
Loss of consciousness x
Erythema x
Urinary tract disorder x
Angiopathy x
Vulvitis x
Vulvovaginitis x x
Dry mouth x
Polydipsia x
Micturition urgency x
Rash pustular x
Urosepsis x
Blood urea increased x
Malnutrition x
Photosensitivity reaction x
Unspecified disorder of skin and subcutaneous tissue x
Rash macular x
Rash vesicular x
Rash erythematous x
Blood creatinine increased x x
Haematocrit increased x
Recurrent infection x x
Dyslipidaemia x
Balanitis candida x x
Diabetic complication x
Photosensitivity x
Vaginal infection x
Rash maculo-papular x
Rash generalised x
Hypovolaemia x x
Low density lipoprotein increased x
Serum potassium increased x x
Serum creatinine increased x x
Vulvovaginal candidiasis x x
Glomerular filtration rate decreased x
Blood phosphate increased x
Blood potassium increased x
Glucose low x
Urine output increased x
Rash papular x
Vulvovaginal mycotic infection x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

canagliflozin anhydrous

Side effects:45
Source:FDA Structured Product Label

canagliflozin / canagliflozin

Side effects:56
Source:EMA

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label